abstract Objective: The aim was to formulate practice guidelines for the diagnosis and
treatment of hyperprolactinemia. Participants: The Task Force consisted of Endocrine …

Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …

Fisetin is one of the most popular flavonoids found in vegetables and fruits with several
health benefits such as antidiabetic, anticancer, and anti‐inflammatory activities …

In children and adolescents the Second Generation Antipsychotics (SGAs) represent the
class of psychotropic drugs whose use has grown more significantly in recent years: they are …

Hyperprolactinaemia is a common side effect in people receiving antipsychotics. The
propensity to cause hyperprolactinaemia differs markedly between antipsychotics as a result …

Optimizing antipsychotic pharmacotherapy is often challenging due to significant variability
in effectiveness and tolerability. Genetic factors influencing pharmacokinetics and …

Pediatric behavioral and affective disorders often require antipsychotic therapy, in
combination with psychotherapeutic interventions, for their treatment and stabilization …

Cytochrome P450 enzyme especially CYP2D6 plays a major role in biotransformation. The
interindividual variations of treatment response and toxicity are influenced by the …

Introduction: Antipsychotics represent a large portion of the psychotropics that may induce
hyperprolactinemia. Clinical psychiatric pharmacists must be adept in stratifying the relative …

The treatment of severe mental illness, and of psychiatric disorders in general, is limited in
its efficacy and tolerability. There appear to be substantial interindividual differences in …